References
- Non Small Cell Lung Cancer Cooperative Group. Chemotherapy in non small cell lung cancer: a meta analysis using updated data on individual patients from 52 random-ized clinical trials. Br Med J 1995; 311: 899–909.
- Baldini E, Tibaldi C, Chella A, et al. Combination chemotherapy with vinorelbine, ifosfamide and cisplatin: a phase II study IIIB-IV non small cell lung cancer. Semin Oncol 1994; 21 (suppl 4): 12-15.
- Hohneker JA. A summary of vinorelbine (navelbine) safety data from North American clinical trials. Semin Oncol 1994; 21 (5, suppl. 10): 42-44.
- Viallet J, Ayoub J, Rousseau P, Sohuami L, Hoheneker J, Shepherd F. Vinorelbine in the adjuvant and neoadjuvant treatment of non small cell lung cancer. Semin Oncol 1994; 21 ( 5, suppl. 10): 64-72.
- Vokes EE, Rosenberg RK, Jahanzeb M, et al. Multicenter phase II study of weekly oral vinorelbine for stage IV non small cell lung cancer. J Clin Oncol 1995; 13 (3): 637–644.
- Wargin WA, Sol Lucas V. The clinical pharmacokinetics of vinorelbine. Semin Oncol 1994; 21 ( 5, suppl. 10): 21-27.
- Crawford F. Vinorelbine ( Navelbine) in non small cell lung cancer: Future directions. Semin Oncol 1994; 21 ( 5, suppl. 10): 85-88.
- Clerici M, Bretti S, Celano A, et al. Trattamento nel car-cinoma polmonare non a piccole cellule con vinorelbina in monochemioterapia. Minerva Pneumolog 1994; 33 (4): 269–272.
- Colleoni M, Gaion F, NelLi P, Colmellere GM, Manente P. Weekly vinorelbine in elderly patients with non small cell lung cancer. Tumori 1994; 80: 448–452.
- Crivellari D, Veronesi A, Sacco C, Magri MD, Buonadonna A, Foladore S, Monfrdini S. Phase II study of vinorelbine in 50 patients with non small cell lung cancer (Meeting Abstract). Proc Am Soc Clin Oncol 1994; 13: 92.
- Le Chevalier T, Pujol JL, Douillard JY, et al. A three arm trial of vinorelbine (navelbine) plus cisplatin, vindesine plus cisplatin, and single agent vinorelbine in the treatment of non small cell lung cancer: An expanded analysis. Semin Oncol 1994; 21 (5, suppl. 10): 28-34.
- Fernandes C., Rossel R., Abda-Estave A. Quality of life during chemotherapy in non small cell lung cancer. Acta Oncol 1989; 28: 129–133.
- Regan J, YamoId J, Jones PV, Cooke WJ. Palliation and life quality in lung cancer: how good are clinicians for judging outcome? Br J Cancer 1991; 2: 396–400.
- Raby B, Pater J, Mackillop WJ. Does knowledge guide practice? Another look at the management of non small cell lung cancer. J Clin Oncol 1995; 13 (8): 1904–1911.
- Souquet PJ, Chauvin F, Boissel JP, et al. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet 1993; 342: 19–21.
- Smith TJ, Hillner BE, Neighbors DM, McSorley PA, Le Chevalier T. Economical evaluation of a randomized clini-cal trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non small cell lung cancer. J Clin Oncol 1995; 13 (9): 2166–2173.
- Livingstone RB. Current management of unresectable non small cell lung cancer. Semin Oncol 1994; 21 (5, suppl. 10): 4-13.
- Lorusso V, Pezzella G, Catino AM, et al. Results of clinical multicenter randomized phase II study of non small cell lung cancer treated with vinorelbine-cisplatin versus vinorelbine alone. Int J Oncol 1995; 6: 65–68.
- Bergeron E, Raffy O, Vannetzel JM. Myocardial ischemia and infarction associated with vinorelbine. J Clin Oncol 1995; 13 (2): 531.